Delivery Order SPE2DR25D1109-SPE2DR26FFK9G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,825.11 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price, non-set-aside contract represents a small-value pharmaceutical delivery supporting the agency's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,235.76 for NURTEC ODT 75 MG tablets (8-count) on December 2, 2025, with completion scheduled for December 3, 2025. This competitive, non-set-aside award reflects a firm fixed price contract for pharmaceutical delivery to support federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $58,252.86 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) under a firm fixed price contract. The order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $8,330.33 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare...
- The Defense Logistics Agency awarded a Delivery Order valued at $8,406.33 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). This competitively awarded, firm fixed-price contract was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $10,522.29 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (quantity 8 units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order valued at $5,753.37 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-pack units) with an ultimate completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,971.19. The contract is scheduled for completion by December 30, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,426.65 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed price arrangement. The award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $80,349.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (quantity: 8 units). This firm fixed-price, non-set-aside delivery order is expected to be completed by January 16, 2026, with performance fulfilled at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFK9GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,676.74 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 16, 2026, with completion targeted for January 20, 2026. This firm fixed-price, competitively awarded contract (no set-aside) is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds an even larger IDC with the DLA valued at $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle. These contracts enable the delivery of a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities required to support military healthcare programs worldwide and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 1/15/26 |